Steffan Joe's Album: Wall Photos

Photo 5 of 8 in Wall Photos

Global Psychedelic
therapeutics market is estimated to be worth over USD 6.5 billion in 2030,
predicts Roots Analysis

A growing body of evidence suggests that using
psychedelics, such as psilocybin and LSD, in combination with psychotherapy,
can treat the symptoms of several mental health conditions, including
depression and substance use disorders

Roots Analysis has announced the
addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

The report features an extensive study of the current
market landscape, offering an informed opinion on the likely adoption of these
therapies over the next decade. It features an in-depth analysis, highlighting
the capabilities of various stakeholders engaged in this domain. In addition to
other elements, the study includes:

A detailed assessment of the current market landscape of
drug developers engaged in the development of psychedelic therapeutics.

Tabulated profiles of prominent psychedelic therapeutics
developers. shortlisted on the basis of the number of pipeline products).

Detailed profiles of developers of next generation immune
checkpoint modulators (shortlisted on the basis having two or more
psychedelics-based therapies in phase II clinical studies and above).

An insightful analysis of clinical trial sites where the
studies have been / are being conducted for evaluation of various psychedelic

A list of key opinion leaders (KOLs) within this domain,
and detailed 2×2 matrices to assess the relative experience of key individuals
who were shortlisted based on their contributions (in terms of involvement in
various clinical studies) to this field.

A detailed analysis of nearly 545 grants that have been
awarded to research institutes engaged in psychedelic therapeutics projects, in
the period between 2015 and 2020 (till May).

An analysis of the partnerships that have been established
in the recent past (2017-2020 till May),

A detailed analysis of the various mergers and acquisitions
that have taken place in this domain, highlighting the trend in the number of
companies acquired between 2017-2020.

A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed

§ Target
Disease Indication

Anxiety and Depression


Pain Disorder

Sleep related Disorder

§ Origin of
Psychedelic Substance



§ Type of
Psychedelic Substance





§ Route of




§ Key

North America



companies covered in the -

Celon Pharma

iX Biopharma

MAPS Public Benefit


Janssen Pharmaceuticals

Jazz Pharmaceutical

For additional details, please

You may also be interested in the
following titles:

1. Endocannabinoid System
Targeted Therapeutics Market, 2020-2030

2. Depressive Disorders
(Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant
Depression and Others): Pipeline Review, Developer Landscape and Competitive
Insights, 2019

3. Alzheimer's Disease:
Pipeline Review, Developer Landscape and Competitive Insights

Neoantigen Targeted
Therapies Market, 2019-2030

5. Blood-Brain Barrier
(BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery
Technology Platforms and Therapeutics

About Roots Analysis

Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at

Contact Information

Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Facebook -

LinkedIn -